Company intelligence / Profile preview

GeneLife

Ownership: Private
Development stage: Commercial

Overview

GeneLife is primarily known as the direct-to-consumer genetic testing brand of Genesis Healthcare, a leading Japanese biotech company focused on preventive healthcare via personal genomics. The company has served over 857,000 users with validated science tailored to East Asian populations using proprietary technology platforms. Separately, there are unrelated entities named "Genelife" operating as a clinical research organization in India and a CDMO in Italy—both providing B2B services to pharma/biotech clients rather than developing their own drugs or diagnostics.

Therapeutic areas: Other
Modalities: Genetic testing services (DTC genetics)
Industry: Molecular Diagnostics

Beyond the preview

Go deeper on GeneLife.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on GeneLife.

Explore the full profile